Hims & Hers to offer at-home blood draws and lab testing

Hims & Hers to offer at-home blood draws and lab testing with new acquisition
Hims & Hers is expanding its offerings through the Trybe Labs deal after it added compounded weight loss drugs.
Hims & Hers Buys Lab to Expand Into At-Home Blood Testing
Hims & Hers Health Inc. is expanding beyond its successful foray into providing copycat weight-loss drugs with the acquisition of a home blood-testing company.
Hims & Hers To Launch At-Home Blood Testing With Lab Company Purchase
Hims & Hers is introducing at-home laboratory testing, expanding its platform to offer deeper health insights and more precise clinical decision-making. Hims & Hers Health, Inc. is acquiring Kearny, New Jersey-based
Hims & Hers acquires at-home lab testing facility, terms undisclosed
Hims & Hers announced its plans to introduce at-home lab testing through its platform. The company has acquired an at-home lab testing
Hims & Hers Health stock soars on Trybe Labs acquisition
The acquisition of Trybe Labs, marketed as Sigmund NJ LLC, will enable Hims & Hers to offer comprehensive whole body testing, including at-home blood draws. This addition to the company’s services is anticipated to facilitate improved clinical decision-making by providing providers with a broader range of data and biomarkers.
Hims & Hers Health Shares Hit All-Time High After Testing Facility Buy
The stock was up 15% to $67.28 in Tuesday morning trading, after touching an all-time high of $70.50. Shares of Hims & Hers have been setting new all-time highs in the past month, and have more than doubled in price in that time.
Why Hims & Hers Health (HIMS) Is Rallying Today
Hims & Hers Health (HIMS) is jumping 15% after the company announced that it had made an acquisition which will allow it to ...
Her Campus3h
Hims & Hers Super Bowl Ad Hypocritically Fuels Fatphobia
The Super Bowl aired a Hims & Hers commercial that is receiving backlash for its non-FDA approved weight loss drug. This drug ...
Super Bowl ad for Hims & Hers' weight loss drug sparks backlash
The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...
Hims & Hers Q4 Preview: Is The Super Bowl Ad Worth $5B In Market Cap? (Rating Downgrade)
Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...
HIMS Stock Hits New ATH After Successful Super Bowl Ad
Hims & Hers Health (HIMS) stock hit a new all-time high on Thursday as retail investors have taken interest in the telehealth ...
Hims & Hers Stock Soars on Momentum From Super Bowl Ad, RFK Confirmation
Shares of Hims & Hers Health, the telehealth provider that has found a niche in the obesity-drug boom, surged 28% on Thursday ...
Hosted on MSN1d
Hims & Hers Stock Jumps 156.9% in Three Months: What's Next?
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late. Shares of the ...
MarketBeat on MSN1d
Hims & Hers: From Viral Ad to Volatile Stock
Hims & Hers Health's (NYSE: HIMS) share price has surged recently, climbing above $60 and creating new 52-week and all-time ...